Potential mechanisms by which MAD2L2 rs746218 and TNFRSF1A rs4149570 impacted prognosis in patients with lung cancer who received platinum-based chemotherapy were determined using TCGA data (https://portal.gdc.cancer.gov/). The gene discussed is MAD2L2; the disease is lung carcinoma.